Literature DB >> 30190977

Malignant transformation of hepatocellular adenoma.

Christine Sempoux1,1, Charles Balabaud2,2, Paulette Bioulac-Sage2,2.   

Abstract

Hepatocellular adenomas carry a risk of malignant transformation. However, little is known about the rate of this risk, the predisposing factors, the histological and/or immunohistochemical markers and the precursor lesions. Even the pathogenesis of malignant transformation itself is poorly understood. This review details the current knowledge on the subject.

Entities:  

Keywords:  hepatocellular adenoma; hepatocellular carcinoma; histopathology; immunohistochemistry; malignant transformation; β-catenin activation

Year:  2014        PMID： 30190977      PMCID： PMC6095435          DOI： 10.2217/hep.14.14

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


  49 in total

1.  Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy.

Authors:  S Van der Borght; L Libbrecht; A Katoonizadeh; R Aerts; F Nevens; C Verslype; T A Roskams
Journal:  Histopathology       Date:  2007-09-28       Impact factor: 5.087

2.  Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives.

Authors:  M Davis; B Portmann; M Searle; R Wright; R Williams
Journal:  Br Med J       Date:  1975-11-29

3.  Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.

Authors:  Susanna M van Aalten; Joanne Verheij; Turkan Terkivatan; Roy S Dwarkasing; Robert A de Man; Jan N M Ijzermans
Journal:  J Hepatol       Date:  2010-11-24       Impact factor: 25.083

Review 4.  Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions.

Authors:  Isela Velazquez; Blanche P Alter
Journal:  Am J Hematol       Date:  2004-11       Impact factor: 10.047

Review 5.  Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

Authors:  György Baffy; Elizabeth M Brunt; Stephen H Caldwell
Journal:  J Hepatol       Date:  2012-02-09       Impact factor: 25.083

6.  Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms.

Authors:  Sanjay Kakar; Xin Chen; Coral Ho; Lawrence J Burgart; Oyedele Adeyi; Dhanpat Jain; Viabhav Sahai; Linda D Ferrell
Journal:  Histopathology       Date:  2009-08       Impact factor: 5.087

7.  Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.

Authors:  Julien Calderaro; Philippe Labrune; Guillaume Morcrette; Sandra Rebouissou; Dominique Franco; Sophie Prévot; Alberto Quaglia; Pierre Bedossa; Louis Libbrecht; Luigi Terracciano; G Peter A Smit; Paulette Bioulac-Sage; Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2012-10-06       Impact factor: 25.083

Review 8.  Benign hepatocellular nodules: what have we learned using the patho-molecular classification.

Authors:  Christine Sempoux; Charissa Chang; Annette Gouw; Laurence Chiche; Jessica Zucman-Rossi; Charles Balabaud; Paulette Bioulac-Sage
Journal:  Clin Res Hepatol Gastroenterol       Date:  2013-07-19       Impact factor: 2.947

9.  Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy.

Authors:  Jeremiah L Deneve; Timothy M Pawlik; Steve Cunningham; Bryan Clary; Srinevas Reddy; Charles R Scoggins; Robert C G Martin; Michael D'Angelica; Charles A Staley; Michael A Choti; William R Jarnagin; Richard D Schulick; David A Kooby
Journal:  Ann Surg Oncol       Date:  2009-01-08       Impact factor: 5.344

10.  Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Gabrielle Couchy; Brigitte Le Bail; Antonio Sa Cunha; Anne Rullier; Christophe Laurent; Jean-Frédéric Blanc; Gaelle Cubel; Hervé Trillaud; Jessica Zucman-Rossi; Charles Balabaud; Jean Saric
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425
View more
  6 in total

1.  Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.

Authors:  Juan Putra; Linda D Ferrell; Annette S H Gouw; Valerie Paradis; Arvind Rishi; Christine Sempoux; Charles Balabaud; Swan N Thung; Paulette Bioulac-Sage
Journal:  Mod Pathol       Date:  2019-09-30       Impact factor: 7.842

Review 2.  Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations.

Authors:  Elan Hahn; Juan Putra
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

3.  Malignant transformation of hepatocellular adenoma.

Authors:  Céline Julien; Brigitte Le Bail; Laurence Chiche; Charles Balabaud; Paulette Bioulac-Sage
Journal:  JHEP Rep       Date:  2022-01-07

Review 4.  A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.

Authors:  Federica De Muzio; Francesca Grassi; Federica Dell'Aversana; Roberta Fusco; Ginevra Danti; Federica Flammia; Giuditta Chiti; Tommaso Valeri; Andrea Agostini; Pierpaolo Palumbo; Federico Bruno; Carmen Cutolo; Roberta Grassi; Igino Simonetti; Andrea Giovagnoni; Vittorio Miele; Antonio Barile; Vincenza Granata
Journal:  Diagnostics (Basel)       Date:  2022-07-07

5.  A case of hepatocellular adenoma with pedunculated development and difficulty in diagnosis.

Authors:  Norihiko Kawabe; Takahiko Higashiguchi; Hironobu Yasuoka; Toki Kawai; Kenshiro Kamio; Takayuki Ochi; Chihiro Hayashi; Masahiro Shimura; Shinpei Furuta; Satoshi Arakawa; Yuka Kondo; Yukio Asano; Hidetoshi Nagata; Masahiro Ito; Akihiko Horiguchi; Zenichi Morise
Journal:  Fujita Med J       Date:  2019-11-02

6.  Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas.

Authors:  Sophie Chopinet; François Cauchy; Christian Hobeika; Aurélie Beaufrère; Nicolas Poté; Olivier Farges; Safi Dokmak; Mohamed Bouattour; Maxime Ronot; Valérie Vilgrain; Valérie Paradis; Olivier Soubrane
Journal:  JHEP Rep       Date:  2021-06-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.